All posts by: Michael Zand

Possible master switch for programming cancer immunotherapy
Science Daily
Finding the factors that cause T cells to function beyond the lymphoid system and in sites of infection or cancer has proven a tough challenge, but it’s essential for developing cancer-fighting immunotherapy strategies. Writing in the journal Nature …

and more »

News of Note—Superstrong eye repair; gene therapy for ‘bubble boy’ disease; mapping genetic risks for brain disorders
FierceBiotech
Now scientists at St. Jude Children’s Research Hospital have early evidence that a gene therapy they developed could be a promising cure for the disease. The therapy delivers a normal copy of IL2RG—the gene that becomes mutated to cause the disease …

CAR T Cells in Advanced R/R Lymphoma: Keeping Patients Alive
Medscape
ATLANTA — New longer-term clinical data with chimeric antigen receptor (CAR) T cells now reported for patients with refractory and relapsed non-Hodgkin’s lymphoma show that the responses are durable in about half of those treated, with the suggestion …
CAR T cell therapy shows long-lasting remissions in non-Hodgkin’s lymphoma patientsNews-Medical.net
CAR T-Cell Therapies Drive Outcomes in Lymphoma, MyelomaPR Newswire (press release)
Autolus presents data for pan-checkpoint blocking tech to restore CAR T-cells‘ functionEPM Magazine
Popular Science –Medical Xpress
all 22 news articles »

CAR T Cells in Advanced R/R Lymphoma: Keeping Patients Alive
Medscape
ATLANTA — New longer-term clinical data with chimeric antigen receptor (CAR) T cells now reported for patients with refractory and relapsed non-Hodgkin’s lymphoma show that the responses are durable in about half of those treated, with the suggestion …
New trials show cancer immunotherapy can be incredibly effective—and incredibly dangerousPopular Science
CAR T-cell therapies drive outcomes in lymphoma, myelomaEurekAlert (press release)
CAR T cell therapy shows long-lasting remissions in non-Hodgkin’s lymphoma patientsNews-Medical.net
Business Wire (press release) –Medical Xpress
all 29 news articles »

Scientists discover possible master switch for programming cancer immunotherapy
Medical Xpress
Finding the factors that cause T cells to function beyond the lymphoid system and in sites of infection or cancer has proven a tough challenge, but it’s essential for developing cancer-fighting immunotherapy strategies. Writing in the journal Nature …

and more »

Two Groundbreaking Gene Therapy Studies Hint At Cure For Hemophilia
IFLScience
Gene therapy in humans may still be in its infancy, but it’s already making some previously impossible stories a reality. From editing out the symptoms of sickle cell disease to curing two baby girls of an incurable form of leukemia, the future is …